Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture

This paper demonstrates multiple benefits of intravitreal bevacizumab (IVB) on diabetic retinopathy (DR) including diabetic macular edema (DME) and proliferative diabetic retinopathy (PDR) at 24 months of followup. This is a retrospective multicenter interventional comparative case series of intravi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arevalo, J. Fernando, Sanchez, Juan G., Lasave, Andres F., Wu, Lihteh, Maia, Mauricio, Bonafonte, Sergio, Brito, Miguel, Alezzandrini, Arturo A., Restrepo, Natalia, Berrocal, Maria H., Saravia, Mario, Farah, Michel Eid, Fromow-Guerra, Jans, Morales-Canton, Virgilio
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090772/
https://www.ncbi.nlm.nih.gov/pubmed/21584260
http://dx.doi.org/10.1155/2011/584238

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090772/
https://www.ncbi.nlm.nih.gov/pubmed/21584260
http://dx.doi.org/10.1155/2011/584238

Ejemplares similares